Biomedical Applications of Polyurethanes: A Review of Past Promises, Present Realities, and a Vibrant Future
- 1 July 1999
- journal article
- review article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 14 (1), 67-90
- https://doi.org/10.1177/088532829901400104
Abstract
Polyurethanes, having extensive structure/property diversity, are one of the most bio- and blood-compatible materials known today. These materials played a major role in the development of many medical devices ranging from catheters to total artificial heart. Properties such as durability, elasticity, elastomer-like character, fatigue resistance, compliance, and acceptance or tolerance in the body during the healing, became often associated with polyurethanes. Furthermore, propensity for bulk and surface modification via hydrophilic/hydrophobic balance or by attachments of biologically active species such as anticoagulants or biorecognizable groups are possible via chemical groups typical for polyurethane structure. These modifications are designed to mediate and enhance the acceptance and healing of the device or implant. Many innovative processing technologies are used to fabricate functional devices, feeling and often behaving like natural tissue. The hydrolytically unstable polyester polyurethanes were replaced by more resistant but oxidation-sensitive polyether polyols based polyurethanes and their clones containing silicone and other modifying polymeric intermediates. Chronic in vivo instability, however, observed on prolonged implantation, became a major roadblock for many applications. Presently, utilization of more oxidation resistant polycarbonate polyols as soft segments, in combination with antioxidants such as Vitamin E, offer materials which can endure in the body for several years. The applications cover cardiovascular devices, artificial organs, tissue replacement and augmentation, performance enhancing coatings and many others. In situ polymerized, cross-linked systems could extend this biodurability even further. The future will expand this field by revisiting chemically-controlled biodegradation, in combination with a mini-version of RIM technology and minimally invasive surgical procedures, to form, in vivo, a scaffold, by delivery of reacting materials to the specific site in the body and polymerizing the mass in situ. This scaffold will provide anchor for tissue regeneration via cell attachment, proliferation, control of inflammation, and healing.Keywords
This publication has 33 references indexed in Scilit:
- Uptake of drugs by catheters: the influence of the drug molecule on sorption by polyurethane cathetersBiomaterials, 1996
- Glass Wool–H2O2/CoCl2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomersJournal of Biomedical Materials Research, 1995
- Polymer hollow fiber membranes for removal of toxic substances from bloodProgress in Polymer Science, 1989
- Polyether polyurethanes for implantable pacemaker leadsBiomaterials, 1982
- Thermoplastic Polyurethane Elastomer Melt Polymerization StudyRubber Chemistry and Technology, 1982
- A New Investigation of Tetrahydrofuran-Based Polyether Glycols in Urethane ElastomersRubber Chemistry and Technology, 1980
- Polyether Based Thermoplastic Polyurethanes Effect of the Soft Segment Molecular WeightJournal of Elastomers & Plastics, 1980
- Transition behavior and phase segregation in TDI polyurethanesPolymer Engineering & Science, 1977
- Development of block copolyether‐urethane intra‐aortic balloons and other medical devicesJournal of Biomedical Materials Research, 1973
- Properties of linear elastomeric polyurethanesJournal of Applied Polymer Science, 1966